核酸分离纯化市场增长、趋势、COVID-19 的影响和预测 (2023-2028)

在预测期内，核酸分离纯化市场预计将以 6.6% 的复合年增长率增长。

核酸分离和纯化市场的增长得益于快速的技术进步、核酸检测在诊断领域的广泛应用，以及生物技术和医疗保健领域研发资金的增加。

主要亮点

• 核酸用于许多疾病的诊断测试，包括性传播疾病、出生缺陷和癌症。
• 根据美国卫生与公众服务部的数据，截至 2016 年，全球约有 3670 万艾滋病毒/艾滋病感染者。 其中，210 万是儿童（15 岁及以上）。 世界卫生组织表示，全世界每天有超过 100 万人感染性传播疾病，其中 5 亿人感染了单纯疱疹病毒 (HSV) 的生殖器，2.9 亿女性感染了人乳头瘤病毒 (HPV)。我假设它已被感染。 因此，所有性传播疾病都可以通过核酸分离鑑定程序进行诊断，这意味着研究目标市场有望在全球范围内扩大。
• 此外，聚合酵素炼式反应（最初的核酸扩增技术）等快速技术进步改变了临床微生物学家看待和使用核酸技术的方式，目前的市场正在不断扩大。

核酸分离纯化市场趋势

核酸分离纯化市场，设备板块有望占据较大份额

• 在接受调查的市场中，设备行业呈稳定增长态势。 分子诊断领域的重大进步正在推动核酸分离和纯化技术的快速和持续进步。 在绘製许多疾病背后的遗传风险因素的新知识的推动下，生活方式正在发挥重要作用。
• 根据世界卫生组织 (WHO) 2020 年版，ALPHA 和BETA 地中海贫血已被发现是全世界最常见的遗传性单基因疾病。 在世界许多地方，地中海贫血的负担是一个主要的公共卫生问题。 例如，在伊朗，估计每年约有 8,000 名孕妇有患该病的风险。 此外，据估计，全世界每 1,000 至 1,100 名活产婴儿中就有 1 例患有唐氏综合症，这是一种遗传性疾病。
• 因此，遗传病的高发病率以及实验室自动化程度和顽固性的提高可能会导致所研究市场设备部分的增长。

北美将占据很大的市场份额，预计在预测期内也会如此

• 由于下游用途的绝对数量，预计北美将在核酸分离和纯化市场占据主要市场份额。 市场增长还归因于快速的技术进步、核酸检测在推动市场的诊断中的广泛应用，以及生物技术和医疗保健领域研发资金的增加。
• 根据美国疾病控制和预防中心 (CDC) 的数据，美国每 5,000 名新生儿中就有 1 名患有 A 型血友病。 每年约有 400 名婴儿出生时患有 A 型血友病。
• 此外，完善的医疗保健基础设施也在推动该地区整体市场的增长。

核酸分离纯化市场竞争者分析

核酸分离纯化市场是一个由几家大型企业组成的分散且竞争激烈的市场。 全球核酸分离纯化市场的近期市场趋势包括新产品开发、併购和合作伙伴关係。 Agilent Technologies、Bio-Rad Laboratories Inc.、Danaher Corporation、F. Hoffmann-La Roche Ltd、GE Healthcare、Promega Corporation、Qiagen NV、Thermo Fisher Scientific Inc. 是核酸分离和纯化市场的主要参与者。

其他福利。

• Excel 格式的市场预测 (ME) 表
• 三个月的分析师支持

内容

第一章介绍

• 调查结果
• 调查假设
• 本次调查的范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

• 市场概览
• 市场驱动因素
  • 通过快速的技术进步加速市场增长
  • 核酸检测在诊断领域的广泛应用推动了市场的发展
  • 增加生物技术和医疗保健领域的研发资金
• 市场製约因素
  • 在新兴市场的渗透率较低
  • 自动化设备成本上升
• 波特的五力分析
  • 新进入者的威胁
  • 买方/消费者议价能力
  • 供应商的议价能力
  • 替代品的威胁
  • 竞争公司之间的敌对关係

第 5 章市场细分

• 按技术
  • 基于柱的纯化
  • 磁珠纯化
  • 基于试剂的纯化
• 按产品分类
  • 试剂盒和试剂
  • 设备
  • 其他产品
• 通过申请
  • 总RNA的分离和纯化
  • mRNA的分离和纯化
  • microRNA 的分离和纯化
  • 质粒DNA的分离和纯化
  • 基因组 DNA 的分离和纯化
  • 血型DNA的分离纯化
  • PCR 纯化
  • 其他核酸分离和纯化应用
• 最终用户
  • 医院
  • 学术和研究机构
  • 製药/生物技术
  • 其他最终用户
• 按地区
  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 中东和非洲
    • 海湾合作委员会
    • 南非
    • 其他中东和非洲地区
  • 南美洲地区
    • 巴西
    • 阿根廷
    • 其他南美洲

第六章竞争格局

• 公司简介
  • Agilent Technologies
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific
  • BioVision Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Merck KGaA（Sigma-Aldrich Corporation）
  • Promega Corporation
  • Qiagen NV

第7章 市场机会今后动向

The Nucleic Acid Isolation and Purification Market is expected to register a CAGR of 6.6% during the forecast period. growth of the nucleic acid isolation and purification market is due to the rapid technological advancements, wide-range applications of nucleic acid testing in diagnostics, and rise in the R&D funding in biotechnology and healthcare.

Key Highlights

• Nucleic acid has many diagnostic applications in tests of many diseases, such as STDs, congenital anomalies, cancer, etc.
• According to the US Department of Health & Human Services, there were approximately 36.7 million people worldwide living with HIV/AIDS as of 2016. Of these, 2.1 million were children (above 15 years old). The WHO stated that more than 1 million sexually transmitted infections are acquired every day worldwide and 500 million people are estimated to have genital infection with herpes simplex virus (HSV), along with 290 million women who have a human papillomavirus (HPV) infection. Therefore, all STDs can be diagnosed through nucleic acid isolation and identification procedures, and this signifies that the market studied is expected to increase globally.
• The current market is also growing, due to rapid technological advancements, like polymerase chain reaction (the original nucleic acid amplification technique), which transformed the approach of the clinical microbiologists in viewing and using nucleic acid techniques in clinical settings.

Nucleic Acid Isolation & Purification Market Trends

The Equipment Segment is Expected to Hold a Major Market Share in the Nucleic Acid Isolation and Purification Market

• The equipment segment of the market studied is growing at a good pace. There are significant advancements found in the field of molecular diagnostics that have facilitated rapid and continued advancements in nucleic acid isolation and purification technologies, driven by the new knowledge provided by the mapping of genetic risk factors behind many diseases, where lifestyle has an important role to play.
• According to the World Health Organization (WHO) 2020, the alpha and beta thalassaemias are the most common inherited single-gene disorders in the world. The burden of thalassaemias in many regions of the world represents a major public health concern. For example in Iran, it was estimated that each year about 8,000 pregnancies are at risk of this disorder. Moreover, In addition, it was estimated that the incidence of genetic disorder Down syndrome was between 1 in 1,000 to 1 in 1,100 live births worldwide.
• Thus, the high incidence of genetic disorders along with growth in laboratory automation and decreasing changeability may lead to the growth of the equipment segment of the market studied.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

• North America is expected to hold a major market share in the nucleic acid isolation and purification market due to the very high use of downstream processes in the country. The growth of the market is also attributed due to the rapid technological advances, wide-range applications of nucleic acid testing in diagnostics boosting the market, rise in the R&D funding in biotechnology and healthcare.
• According to the Centers for Disease Control and Prevention (CDC), in the United States Hemophilia A affects 1 in 5,000 male births. Each year approximately 400 babies are born with haemophilia A.
• Furthermore, the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Nucleic Acid Isolation & Purification Market Competitor Analysis

The Nucleic Acid Isolation and Purification Market is fragmented competitive and consists of several major players. Some of the recent market trends in the global nucleic acid isolation and purification market are new product development, mergers and acquisition, and partnerships. Agilent Technologies, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, GE Healthcare, Promega Corporation, Qiagen NV, and Thermo Fisher Scientific Inc. are some of the major players in the nucleic acid isolation and purification market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rapid Technological Advancements Boosting the Market Growth
  • 4.2.2 Wide-range Applications of Nucleic Acid Testing in Diagnostics Boosting the Market
  • 4.2.3 Rise in the R&D Funding in Biotechnology and Healthcare
• 4.3 Market Restraints
  • 4.3.1 Low Penetration in the Emerging Markets
  • 4.3.2 Increasing Cost of Automated Instruments
• 4.4 Porter's Five Forces Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Technology
  • 5.1.1 Column-based Purification
  • 5.1.2 Magnetic Bead-based Purification
  • 5.1.3 Reagent-based Purification
• 5.2 By Product
  • 5.2.1 Kits and Reagents
  • 5.2.2 Equipment
  • 5.2.3 Other Products
• 5.3 By Application
  • 5.3.1 Total RNA Isolation and Purification
  • 5.3.2 mRNA Isolation and Purification
  • 5.3.3 microRNA Isolation and Purification
  • 5.3.4 Plasmid DNA Isolation and Purification
  • 5.3.5 Genomic DNA Isolation and Purification
  • 5.3.6 Blood DNA Isolation and Purification
  • 5.3.7 PCR Clean-up
  • 5.3.8 Other Nucleic Acid Isolation and Purification Applications
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Academic and Research Institutes
  • 5.4.3 Pharmaceutical/Biotechnology Industry
  • 5.4.4 Other End Users
• 5.5 Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle-East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle-East & Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Agilent Technologies
  • 6.1.2 Bio-Rad Laboratories Inc.
  • 6.1.3 Thermo Fisher Scientific
  • 6.1.4 BioVision Inc.
  • 6.1.5 Danaher Corporation
  • 6.1.6 F. Hoffmann-La Roche Ltd
  • 6.1.7 GE Healthcare
  • 6.1.8 Merck KGaA (Sigma-Aldrich Corporation)
  • 6.1.9 Promega Corporation
  • 6.1.10 Qiagen NV

7 MARKET OPPORTUNITIES AND FUTURE TRENDS